Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay

被引:20
作者
Chen, Lu [1 ]
Liu, Jingrui [1 ]
Shi, Lei [2 ]
Song, Yang [1 ]
Song, Yujie [1 ]
Gao, Yang [1 ]
Dong, Ying [1 ]
Li, Lin [3 ]
Shen, Min [4 ]
Zhai, Yanhong [1 ]
Cao, Zheng [1 ]
机构
[1] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Lab Med, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Dept Lab Med, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Cent Lab, Beijing, Peoples R China
[4] Med Syst Biotechnol Co Ltd, Reference Lab, Ningbo, Zhejiang, Peoples R China
关键词
IFA; multipositive; prevalence; season; TORCH; HERPES-SIMPLEX-VIRUS; RUBELLA; CYTOMEGALOVIRUS; TOXOPLASMA; WOMEN; PREGNANCY; RISK;
D O I
10.1002/jcla.22828
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background TORCH including the pathogens of Toxoplasma gondii (TOX), rubella virus (RV), cytomegalovirus (CMV), and herpes simplex virus (HSV) causes intrauterine infections and poses a worldwide threat to women especially in pregnancy. In this study, we described the seasonal difference in TORCH infection and analyzed the anti-TORCH IgM multipositive serum samples by the indirect immunofluorescence assays (IFA). Methods To observe the seasonal influence of the anti-TORCH IgG and IgM antibodies, a retrospective study was conducted with 10 669 women (20-40 y old) before pregnancy from August 2016 to July 2017. Totally 199 ELISA anti-TORCH IgM multipositive serum samples were further tested by IFAs for false-positive analysis. Results The prevalence of positive HSV1-IgM, RV-IgM, HSV2-IgM, CMV-IgM, and TOX-IgM in the present population was 6.30%, 2.55%, 1.94%, 1.24%, and 0.67%, respectively. Additionally, the prevalence of positive RV-IgM, CMV-IgM, and HSV1-IgM was statistically different among four seasons, with the highest positive rates of RV-IgM (4.12%) in autumn, CMV-IgM (1.75%) in summer, and HSV1-IgM (7.53%) in winter. The confirmatory IFAs showed that the positive rates of RUV-IgM, CMV-IgM, and HSV2-IgM were significantly different from those in ELISA screening experiments. Interestingly, only 32.7% (65/199) of the TORCH IgM multipositive results were consistent with those by the IFA, indicating that cross-reaction caused false positives were common in ELISA IgM antibody screening. Conclusion The TORCH infection displayed different prevalence among four seasons in our 12-month retrospective study. The IgM multipositives by ELISA screening may need further confirmation analysis due to its relatively high cross-reaction rate.
引用
收藏
页数:6
相关论文
共 25 条
  • [1] Toxoplasma gondii Seropositivity and Co-Infection with TORCH Pathogens in High-Risk Patients from Qatar
    Abu-Madi, Marawan A.
    Behnke, Jerzy M.
    Dabritz, Haydee A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 82 (04) : 626 - 633
  • [2] Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014
    Chang, Caiyun
    Mo, Xianghuan
    Hu, Pei
    Liang, Wenjia
    Ma, Huilai
    An, Zhijie
    Liu, Jun
    Zheng, Huizhen
    [J]. VACCINE, 2015, 33 (28) : 3223 - 3227
  • [3] The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome
    De Carolis, S.
    Santucci, S.
    Botta, A.
    Salvi, S.
    Degennaro, V. A.
    Garufi, C.
    Garofalo, S.
    Ferrazzani, S.
    Scambia, G.
    [J]. LUPUS, 2012, 21 (07) : 773 - 775
  • [4] Lack of seasonality of primary human cytomegalovirus infection in pregnancy
    Formica, Manuela
    Furione, Milena
    Zavattoni, Maurizio
    Rognoni, Vanina
    Arossa, Alessia
    Nazifi, Mariam
    Revello, Maria Grazia
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2012, 53 (04) : 370 - 371
  • [5] Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009-2015
    Getahun, Mekonen
    Beyene, Berhane
    Gallagher, Kathleen
    Ademe, Ayesheshem
    Teshome, Birke
    Tefera, Mesfin
    Asha, Anjelo
    Afework, Aklog
    Assefa, Esete
    HaileMariam, Yoseph
    HaileGiorgis, Yonas
    Ketema, Hiwot
    Shiferaw, Dejenie
    Bekele, Ayenachew
    Jima, Daddi
    Kebede, Amha
    [J]. BMC PUBLIC HEALTH, 2016, 16 : 1 - 7
  • [6] The pathogenesis of human cytomegalovirus
    Griffiths, Paul
    Baraniak, Ilona
    Reeves, Matt
    [J]. JOURNAL OF PATHOLOGY, 2015, 235 (02) : 288 - 297
  • [7] Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination
    Kennedy, Richard B.
    Ovsyannikova, Inna G.
    Haralambieva, Iana H.
    Lambert, Nathaniel D.
    Pankratz, V. Shane
    Poland, Gregory A.
    [J]. HUMAN GENETICS, 2014, 133 (11) : 1407 - 1417
  • [8] Structural basis for the antibody neutralization of Herpes simplex virus
    Lee, Cheng-Chung
    Lin, Li-Ling
    Chan, Woan-Eng
    Ko, Tzu-Ping
    Lai, Jiann-Shiun
    Wang, Andrew H. -J.
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2013, 69 : 1935 - 1945
  • [9] Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing
    Li, Zhiyan
    Yan, Cuiling
    Liu, Ping
    Yan, Rong
    Feng, Zhenru
    [J]. CLINICA CHIMICA ACTA, 2009, 403 (1-2) : 212 - 215
  • [10] Man Shanshan LY, 2017, CHIN J BIRTH HLTH HE, V25, P118